...
首页> 外文期刊>BMC Medical Genomics >Effects of statin on circulating microRNAome and predicted function regulatory network in patients with unstable angina
【24h】

Effects of statin on circulating microRNAome and predicted function regulatory network in patients with unstable angina

机译:他汀类药物对不稳定型心绞痛患者循环微RNA组和预测功能调节网络的影响

获取原文
           

摘要

Background Statin therapy plays a pivotal role in stabilizing the plaque for unstable angina (UA) patients although its mechanism(s) remains largely unexplored. Here we aim to identify microRNAs (miRNAs) mediating the protective effect of statins in UA patients. Methods MiRNAs Array was carried out to compare the circulating whole blood miRNA profile of UA patients treated with (n?=?10) and without statin (n?=?10) and plasma miRNA profile UA patients treated with (n?=?5) and without statin (n?=?5). 22 whole blood miRNAs and 19 plasma miRNAs were found significantly upregulated in statin group. Targets of these miRNAs were predicted by algoritms: Targetscan, Miranda and Diana microT, then clustered according to functions and cell types by using the Database for Annotation, Visualization and Integrated Discovery (DAVID). To reveal the enriched function pathways in human atherosclerotic plaque, we analyzed microarray data from GEO database, Coronary atherosclerotic plaque (n?=?80); macrophages in ruptured plaque (n?=?11); carotid atheroma plaque (n?=?64); advanced carotid atherosclerotic plaque (n?=?29) using Reactome database. Integrated analysis indicated that statin induced miRNAs mainly regulate the signaling pathways of Rho GTPase and hemostasis in human atherosclerotic lesion. In vulnerable plaque, additional immune system signaling was also targeted. Results The data showed target genes regulated by these statin induced miRNAs majorly expressed in i) plaque macrophage and platelet, where they were involved in hemostasis process; ii) in monocyte to regulate NGF apoptosis; iii) and in endothelial cell function in Rho GTPase pathway. Integrate analysis indicated that statin induced miRNAs mainly regulate the signaling pathways of Rho GTPase and hemostasis in human atherosclerotic lesion. Conclusions Our study suggest that statin induces the expression of multiple miRNAs in the circulation of UA patient, which play important roles by regulating signal pathways critical for the pathogenesis of UA.
机译:背景技术尽管他汀类药物的治疗机制尚不清楚,但在稳定不稳定型心绞痛(UA)患者斑块中起着关键作用。在这里,我们旨在鉴定介导他汀类药物对UA患者的保护作用的microRNA(miRNA)。方法进行MiRNAs Array比较,比较接受(n?=?10)和未使用他汀类药物(n?=?10)的UA患者的循环全血miRNA谱和(n?=?5)治疗的UA患者的血浆miRNA谱。 ),但没有他汀(n?=?5)。他汀类药物组发现22个全血miRNA和19个血浆miRNA显着上调。这些miRNA的靶标通过算法进行预测:Targetscan,Miranda和Diana microT,然后使用注释,可视化和集成发现数据库(DAVID)根据功能和细胞类型进行聚类。为了揭示人类动脉粥样硬化斑块中丰富的功能途径,我们分析了来自GEO数据库的冠状动脉粥样硬化斑块(n≥80)的微阵列数据。破裂斑块中的巨噬细胞(n≥11);颈动脉粥样斑块(n≥64);使用Reactome数据库获取晚期颈动脉粥样硬化斑块(n?=?29)。综合分析表明,他汀类药物诱导的miRNA主要调节Rho GTPase的信号通路和人动脉粥样硬化病变的止血作用。在易损斑块中,还靶向了其他免疫系统信号传导。结果数据显示受这些他汀类药物诱导的miRNA调控的靶基因主要表达于:i)斑块巨噬细胞和血小板,它们参与止血过程; ii)在单核细胞中调节NGF凋亡; iii)和在Rho GTPase途径中的内皮细胞功能。整合分析表明,他汀类药物诱导的miRNA主要调控Rho GTPase的信号通路和人动脉粥样硬化病变的止血作用。结论我们的研究表明,他汀类药物可诱导UA患者血液中多种miRNA的表达,并通过调节对UA发病机理至关重要的信号途径发挥重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号